Spontaneous Intracerebral hemorrhage (ICH) accounts for about 15% of all strokes and has a 30-day mortality rate of up to 50% Objective : The spot sign on computed tomography angiography is little known about the relationship between the spot sign and the results of cerebral angiography We retrospectively analyzed the spot sign, digital subtraction angiography results, and other factors.
INTRODUCTION
Material and Methods : From December 2009 to May 2014, DSA was performed in 52 ICH patients with non-specific location or abnormalities on CTA findings. 26 of those patients, whose initial CTA showed the spot sign, were analyzed. Two groups, one with the spot sign in the ventricle (Group A) and others with the spot sign in another location (Group B) were statistically compared.
Results : The mean age of the study subjects was 46.9 years (range, 15 to 80 years) and the percentage of males was 53.8%. Thirteen of 26 patients had ICH without intraventricular hemorrhage, and 6 patients had co-existing IVH. In 17 cases, the DSA results were negative. Seven patients were diagnosed with pseudoaneurysms, and two cases showed developmental venous anomalies. Group A consisted of the 8 patients (30.8%) who showed the spot sign in a ventricle. The number of pseudoaneurysms was statistically significantly higher in Group A than in Group B (71.4% versus 28.6%; OR, 13.3; 95% CI, 1.7-103.8 P = 0.014). All three patients who underwent endovascular treatment were members of Group A (P = 0.022), whereas most (92.3%) of those in Group B underwent surgical evacuation. (P = 0.030).
Conclusion : When CTA shows the spot sign in a ventricle, it is a clue that an existing underlying vascular lesion requires endovascular treatment.
The 'spot sign' on CTA was first described in 2007 by Wada et al., and is defined as "tiny, enhancing foci within hematomas, with or without contrast extravasation" 18) . This is generally interpreted as focal sites of extravasation, a focus of arrested bleeding, or a microvascular abnormality 6) ; however, the exact pathophysiology of the spot sign unknown.
In this study, we assessed digital subtraction angiography (DSA) when a patient's CTA showed the spot sign and analyzed the correlation between the spot sign and the existence of a possible vascular lesion that would lead to hematoma expansion and other factors. 
MATERIALS AND METHODS

RESULTS
Patients characteristics and ICH location
We collected data on these 26 patients over the course of 54 months ( drainage.
Subgroup analysis
The patients were divided into 2 groups based on initial radiographic features: Group A (8 patients) had a spot sign in the ventricle, and Group B (18 patients) had a spot sign in another site. The characteristics of the patients in Groups A and B are presented in Table 2 . 
ILLUSTRATIVE CASES
Case 1.
A 54-year-old man presented with ICH in the left basal ganglia with the spot sign on CTA (Fig. 1) . The DSA findings were negative, but a follow-up brain CT scan showed expansion of hematoma. The patient's neurological deterioration aggravated; hence, he underwent surgical treatment.
Case 2.
A 46-year-old woman presented with ICH in the left cerebellum with no intraventricular expansion (Fig. 2) .
The diagnostic angiogram showed DVA. After conservative care for a few days, the hematoma enlarged and her symptoms worsened; she underwent a surgical procedure. 
Case 3.
A 58-year-old man presented with IVH with the spot sign on CTA (Fig. 3) . DSA showed a saccular pseudoaneurysm in the right posterior choroidal artery. It was successfully treated endovascularly.
Case 4.
A 15-year-old girl presented with ICH and IVH with the spot sign on CTA (Fig. 4) . DSA showed an AVM with a round pseudoaneurysm in the left distal middle cerebral artery. The patient was treated surgically.
DISCUSSION
This is the first study to assess the correlation between the CTA spot sign and the existence of a possible vascular lesion using digital subtraction angiography. CTA is rapid, accessible, and widely available and can be used to predict prognosis and to decide upon a treatments on the basis of an initial emergency diagnosis. American Heart Association (AHA) guidelines suggest that CTA can be used to A B C . Chunyan Lei et al. reported that the presence of IVH is an independents predictors of mortality in ICH patients 11) . In this study, DSA was . In their study, the causes of secondary ICH . However, information on the locations of non-traumatic pseudoaneurysms and those due to other etiologies is not currently available. In our study, three of seven pseudoaneurysms (42.8%) were located in the territory of the distal middle cerebral artery and two cases (28.5%) were located in the posterior cerebral arteries. One pseudoaneurysm was located in the distal intracranial artery, and one was in the vertebral artery. (Table 1) Lee A. Tan , with the spot sign was clipped 17) . Other authors published a case report on endovascular treatment of a pseudoaneurysm that formed due to rupture of an anterior communicating artery aneurysm 10) . Because of their rarity, the natural history and optimal management of pseudoaneurysms are not well understood. Some papers have suggested that DSA is the gold standard for the diagnosis of cerebral pseudoaneurysms 13) and endovascular treatment represents a safe and durable procedure 2) ; however, our results suggest that DSA is appropriate for verifying the pseudoaneurysm when CTA shows the spot sign in a ventricle.
We realize that the sample size in our study is too small to generalize the relationship between the spot sign and a pseudoaneurysm. This paper has a limitation in that patient' data were collected and ana- 
CONCLUSION
It is known from previous studies that the spot sign and IVH are associated with hematoma expansion, and the correlation of pseudoaneurysms on DSA and the spot sign in the ventricle has been confirmed.
When CTA shows the spot sign in a ventricle, it might be a clue that there is an existing underlying vascular lesion that requires endovascular treatment.
In such cases, DSA can provide an accurate diagnosis leading to the proper course of treatment.
